GlassScriptPhysician profile
Steven R Poliakoff
NPI 1376624056
$489.68
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2021: $64.30 · 2022: $55.81 · 2023: $193 · 2024: $29.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $128 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $128.28 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $168.93 | 2021-2024 | Myrisk |
| Astellas Pharma US INC | $123.24 | 2019-2023 | |
| Glaxosmithkline, LLC. | $44.63 | 2021 | |
| Tesaro, INC. | $36.62 | 2019 | |
| Vanda Pharmaceuticals INC. | $34.83 | 2022 | |
| Amgen INC. | $24.26 | 2019 | |
| Abbvie INC. | $21.10 | 2019 | |
| Acera Surgical, INC. | $12.74 | 2019 | |
| Duchesnay USA Incorporated | $11.82 | 2019 | |
| Clovis Oncology, INC. | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Poliakoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.